发明名称 AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE
摘要 Aminoalcohol derivatives (I) are new. Aminoalcohol derivatives of formula (I) and their salts and esters are new. [Image] R 1, R 2H, lower alkyl or amino protecting group; R 3H, lower alkyl or hydroxy protecting group; R 4lower alkyl; n : 1-6; X : O or ND; D : H, Ar, SO 2-lower alkyl, SO 2Ar or A; Y : ethylene, vinylene, ethynylene, ECH 2 or 6-10C arylene (optionally substituted by 1-3 A); E : CO or CHOH; Z : bond or 1-10C alkylene optionally substituted by 1-3 A or B and optionally interrupted by O or S; R 5H, 3-10C cycloalkyl, Ar or 5-7 membered heterocyclyl containing 1-3 O, N and/or S all optionally substituted by 1-3 A or B; R 6, R 7H or A; A : halo, lower alkyl, lower haloalkyl, O-lower alkyl, S-lower alkyl, COOH, COO-lower alkyl, OH, lower aliphatic acyl, NH 2, NH-lower alkyl, N(lower alkyl) 2, lower aliphatic acylamino, CN or NO 2; and B : 3-10C cycloalkyl, Ar or 5-7 membered heterocyclyl containing 1-3 O, N and/or S all optionally substituted by 1-3 A; provided that when R 5 = H then Z is not a bond or linear 1-10C alkylene. ACTIVITY : Immunosuppressive; Dermatological; Antiarthritic; Antirheumatic; Antiinflammatory; Osteopathic; Vasotropic; Gastrointestinal-Gen.; Antiulcer; Hepatotropic; Cardiovascular-Gen.; Respiratory-Gen.; Antiasthmatic; Cardiant; Nephrotropic; Hypotensive; Neuroprotective; Antidiabetic; Antiarteriosclerotic; Muscular-Gen.; Virucide; Antianginal; Antiaggregant; Thrombolytic; CNS-Gen.; Nootropic; Antiparkinsonian; Antidepressant; Anticonvulsant; Cytostatic; Uropathic; Ophthalmological. In a graft versus host reaction model using Lewis and WKAH/Hkm rats administration of 2-amino-2-methyl-5-[5-(5-phenylpentanoyl)thien-2-yl]butan-1-ol (Ia) maleic acid salt (0.008 mg/kg/day p.o.) inhibited host versus graft reaction by 16.0 %. The corresponding value for a combination of (Ia) maleic acid salt (0.008 mg/kg/day p.o.) and cyclosporin A (0.08 mg/kg/day p.o.) was 36.1 % and for cyclosporin A (0.08 mg/kg/day p.o.) was 18.7 %. MECHANISM OF ACTION : Synergist.
申请公布号 PL211954(B1) 申请公布日期 2012.07.31
申请号 PL20030370790 申请日期 2003.01.09
申请人 SANKYO COMPANY, LIMITED 发明人 NISHI TAKAHIDE;SHIMOZATO TAKAICHI;NARA FUTOSHI;MIYAZAKI SHOJIRO
分类号 C07D307/52;A61K;A61K31/34;A61K31/341;A61K31/381;A61K31/40;A61K31/42;A61K31/436;A61K31/519;A61K31/661;A61K31/662;A61K38/00;A61K39/395;A61K45/00;A61P;A61P1/04;A61P1/16;A61P3/10;A61P7/00;A61P7/06;A61P9/00;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P11/00;A61P11/06;A61P11/08;A61P13/12;A61P17/00;A61P17/02;A61P17/04;A61P17/06;A61P19/02;A61P21/00;A61P25/00;A61P25/14;A61P25/16;A61P25/18;A61P25/24;A61P25/28;A61P29/00;A61P31/04;A61P31/12;A61P33/00;A61P35/02;A61P37/00;A61P37/06;A61P43/00;C07D;C07D207/32;C07D207/335;C07D333/20;C07F9/572;C07F9/653;C07F9/655;C07F9/6553 主分类号 C07D307/52
代理机构 代理人
主权项
地址